These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2006-001469-41||Randomized, open label, multicenter ABPM study to evaluate the effects of barnidipine as add-on therapy in patients with hypertension not adequately controlled on therapy with losartan||bad-data|
|Completed, but no date Terminated||2007-000947-88||Therapeutic Strategies of Prevention of Diabetes and Hypertension in Subjects with Metabolic Syndrome and High-Normal Blood Pressure.||bad-data|
|Ongoing||2008-000540-14||Role of the renin-angiotensin system in the cardiovascular, metabolic, neurologic and respiratory response to hypobaric hypoxia during sustained exposure to high altitude.||not-yet-due|
|Ongoing||2008-006379-65||Evaluation of the benefit-risk profile of retinoic acid in the treatment of Cushing`s disease||not-yet-due|
|Ongoing||2010-019986-27||Breathing disorders in heart failure: high altitude hypoxia as a model to define diagnostic tools, therapeutic strategies and gender related differences.||not-yet-due|
|Listed as ongoing, but also has a completion date||2012-001757-21||European Society of Hypertension and Chinese Hypertension League Stroke in Hypertension Optimal Treatment Trial||2020-12-31||bad-data|
|Ongoing||2012-005830-12||Parenteral iron supplementation, chemoreflex response, quality of life and exercise capacity in patients with chronic heart failure Terapia marziale endovenosa, risposte chemoriflesse, qualita' di ...||not-yet-due|
|Ongoing||2014-003459-76||REducing blood pressure Variability in Essential hypertension with RAmipril vErsus Nifedipine GITS Trial Riduzione della variabilità della pressione arteriosa nell’ipertensione essenziale con ramip...||not-yet-due|
|Completed, but no date Terminated||2019-004917-15||Crossover, Double-blind, Phase 2 Study of a Fixed Dose Combination of Reboxetine\Oxybutynin (AD128) Versus Placebo in Obstructive Sleep Apnea (RebOx) Studio di Fase 2, in doppio cieco, cross-over, ...||bad-data|
|Ongoing||2020-000250-94||Mutation-specific therapy for the long QT syndrome Terapia mutazione-specifica per la sindrome del QT lungo||not-yet-due|